Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online June 1, 2012.
Article Versions
- You are currently viewing a Latest version of this article (June 1, 2012 - 04:00).
- View the most recent version of this article
Copyright & Usage
© 2012 The Journal of Rheumatology
Author Information
- Jennifer J.Y. Lee,
- Elaheh Aghdassi,
- Angela M. Cheung,
- Stacey Morrison,
- Anne Cymet,
- Valentina Peeva,
- Carolyn Neville,
- Sara Hewitt,
- Deborah DaCosta,
- Christian Pineau,
- Janet Pope and
- Paul R. Fortin
- From the Division of Health Care and Outcome Research, Toronto Western Research Institute; Divisions of General Internal Medicine and Endocrinology, Department of Medicine and Joint Department of Medical Imaging, the University Health Network; Division of Rheumatology, Department of Medicine, the University Health Network and University of Toronto, Toronto, Ontario; Divisions of Clinical Epidemiology and Rheumatology, McGill University Health Centre, Montreal, Quebec; Division of Rheumatology, Centre de recherche du centre hospitalier universitaire de Québec, Université Laval, Québec City, Quebec; and Division of Rheumatology, St. Joseph’s Health Care Centre, London, Ontario, Canada.
Supported by an operating grant from the Canadian Institutes of Health Research: Health Improvement and Prevention Program in SLE, grant MCT82939. Ms. Lee’s work was supported by the 2010 Canadian Rheumatology Association-Roche Research Studentship. Dr. Cheung is supported by a Canadian Institutes of Health Research Senior Investigator Award. Dr. Fortin is a Distinguished Senior Investigator of The Arthritis Society with additional support from the Arthritis Centre of Excellence, University of Toronto. Dr. Fortin is now a tenured professor of medicine at Université Laval, Quebec City, and receives support from the centre de recherche du centre hospitalier universitaire de Québec. Dr. Fortin has provided consultation services to the following companies in the past year: Astra Zeneca Canada Inc., Bio-Rad Laboratories Inc., Canadian Rheumatology Research Consortium, Eli Lilly and Company, GlaxoSmithKline, MedImmune, Novartis Pharmaceuticals Canada Inc., and UCB Canada Inc. The Centre for Prognostic Studies in Rheumatic Disease – University of Toronto Lupus Clinic is supported in part by The Smythe Foundation, Lupus Ontario, and the Dance for the Cure, the Flare for Fashion, and the Lupus Foundation of Ontario. The McGill University Health Centre Lupus Clinic is partially supported by the Singer Family Fund for Lupus Research.
J.J.Y. Lee, BSc; E. Aghdassi, PhD, Division of Health Care and Outcome Research, Toronto Western Research Institute; A.M. Cheung, MD, PhD, Divisions of General Internal Medicine and Endocrinology, Department of Medicine and Joint Department of Medical Imaging, University Health Network; S. Morrison, BSc, Division of Health Care and Outcome Research, Toronto Western Research Institute; A. Cymet, RN, Division of Rheumatology, Department of Medicine, University Health Network and University of Toronto; V. Peeva, MD, Division of Health Care and Outcome Research, Toronto Western Research Institute; C. Neville, BA, RN, Division of Clinical Epidemiology, McGill University Health Centre; S. Hewitt, BA, Division of Rheumatology, St. Joseph Health Centre; D. DaCosta, PhD; C. Pineau, MD, Division of Clinical Epidemiology, McGill University Health Centre; J. Pope, MD, Division of Rheumatology, St. Joseph’s Health Care Centre; P.R. Fortin, MD, MPH, FRCPC, Division of Health Care and Outcome Research, Toronto Western Research Institute; Division of Rheumatology, Department of Medicine, University Health Network and University of Toronto.
Address correspondence to Dr. P.R. Fortin, CHUQ (CHUL) Research Centre, 2705 boulevard Laurier, Room S-763, Quebec City, Quebec G1V 4G2, Canada. E-mail: paul.fortin@crchuq.ulaval.ca.
Accepted for publication March 21, 2012.